[HTML][HTML] Protein kinase CK2: a potential therapeutic target for diverse human diseases
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of
substrates, controls several signaling pathways, and is implicated in a plethora of human …
substrates, controls several signaling pathways, and is implicated in a plethora of human …
Akt in cancer: Mediator and more
S Revathidevi, AK Munirajan - Seminars in cancer biology, 2019 - Elsevier
Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling
pathway. The Akt can be activated by a wide range of growth signals and the biochemical …
pathway. The Akt can be activated by a wide range of growth signals and the biochemical …
[HTML][HTML] Regulating tumor suppressor genes: post-translational modifications
L Chen, S Liu, Y Tao - Signal transduction and targeted therapy, 2020 - nature.com
Tumor suppressor genes cooperate with each other in tumors. Three important tumor
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …
[HTML][HTML] Interaction modules that impart specificity to disordered protein
K Cermakova, HC Hodges - Trends in biochemical sciences, 2023 - cell.com
Intrinsically disordered regions (IDRs) are especially enriched among proteins that regulate
chromatin and transcription. As a result, mechanisms that influence specificity of IDR-driven …
chromatin and transcription. As a result, mechanisms that influence specificity of IDR-driven …
[HTML][HTML] Hybrid drugs—a strategy for overcoming anticancer drug resistance?
M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - mdpi.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …
[HTML][HTML] CK2 in cancer: cellular and biochemical mechanisms and potential therapeutic target
MMJ Chua, CE Ortega, A Sheikh, M Lee… - Pharmaceuticals, 2017 - mdpi.com
CK2 genes are overexpressed in many human cancers, and most often overexpression is
associated with worse prognosis. Site-specific expression in mice leads to cancer …
associated with worse prognosis. Site-specific expression in mice leads to cancer …
Strategies of targeting CK2 in drug discovery: challenges, opportunities, and emerging prospects
Y Chen, Y Wang, J Wang, Z Zhou, S Cao… - Journal of Medicinal …, 2023 - ACS Publications
CK2 (casein kinase 2) is a serine/threonine protein kinase that is ubiquitous in eukaryotic
cells and plays important roles in a variety of cellular functions, including cell growth …
cells and plays important roles in a variety of cellular functions, including cell growth …
[HTML][HTML] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann, CD Baldus - Molecular and cellular therapies, 2015 - Springer
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[HTML][HTML] IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
Abstract Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are
essential for normal lymphoid development. In their absence, severe combined …
essential for normal lymphoid development. In their absence, severe combined …
[HTML][HTML] The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies
HJ Chon, KJ Bae, Y Lee, J Kim - Frontiers in pharmacology, 2015 - frontiersin.org
The casein kinase 2 (CK2) protein kinase is a pro-survival kinase and therapeutic target in
treatment of various human cancers. CK2 overexpression has been demonstrated in …
treatment of various human cancers. CK2 overexpression has been demonstrated in …